Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017)

Insight Molecular Diagnostics (IMDX) posted Change in Acquisitions & Divestments of $432000.0 for Q2 2017, down 13.94% sequentially from $502000.0 in Q1 2017.

Insight Molecular Diagnostics (IMDX) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends

Insight Molecular Diagnostics has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $432000.0 in Q2 2017.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $432000.0 in Q2 2017, while the trailing twelve-month figure through Dec 2017 was $934000.0 (changed N/A YoY) and the FY2023 annual result came in at $367000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments fell to $432000.0 in Q2 2017 per IMDX's latest filing, from $502000.0 in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $771000.0 in Q4 2015 and troughed at $432000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Insight Molecular Diagnostics 172.42 Mn 143.49 Mn 15,000.00

Historic Data

Download Data
DateValue
Jun 30, 2017 432,000.00
Jun 30, 2017 432,000.00
Mar 31, 2017 502,000.00
Mar 31, 2017 502,000.00
Dec 31, 2015 771,000.00
Dec 31, 2015 771,000.00